Expression of aldosterone synthase and adrenocorticotropic hormone receptor in adrenal incidentalomas from normotensive and hypertensive patients: Distinguishing subclinical or atypical primary aldosteronism from adrenal incidentaloma

B BülowS JanssonC JuhlinAdrenal incidentaloma - follow-up results from a Swedish prospective studyEur J Endocrinol154419423200616498055

S DoumaK PetidisM DoumasPrevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational studyLancet37119211926200810.1016/S0140-6736(08)60834-X18539224

S MonticoneA ViolaD TizzaniPrimary aldosteronism: who should be screened?Horm Metab Res44163169201210.1055/s-0031-129540922120135

Y ItoR TakedaS KarashimaPrevalence of primary aldosteronism among prehypertensive and stage 1 hypertensive subjectsHypertens Res3498102201110.1038/hr.2010.16620927116

A JoseNM KaplanPlasma renin activity in the diagnosis of primary aldosteronism: failure to distinguish primary aldosteronism from essential hypertensionArch Intern Med123141146196910.1001/archinte.1969.003001200290045812600

PF PlouinX JeunemaitreWould wider screening for primary aldosteronism give any health benefits?Eur J Endocrinol151305308200410.1530/eje.0.151030515362958

RS VasanJC EvansMG LarsonSerum aldosterone and the incidence of hypertension in nonhypertensive personsN Engl J Med3513341200410.1056/NEJMoa03326315229305

C MattssonWF Young JrPrimary aldosteronism: diagnostic and treatment strategiesNat Clin Pract Nephrol2198208200610.1038/ncpneph015116932426

WF Young JrMinireview: primary aldosteronism - changing concepts in diagnosis and treatmentEndocrinology14422082213200310.1210/en.2003-027912746276

MH BassettB MayhewK RehmanExpression profiles for steroidogenic enzymes in adrenocortical diseaseJ Clin Endocrinol Metab9054465455200510.1210/jc.2005-083615985477

JM ConnellR FraserSM MacKenzieThe impact of polymorphisms in the gene encoding aldosterone synthase (CYP11B2) on steroid synthesis and blood pressure regulationMol Cell Endocrinol217243247200410.1016/j.mce.2003.10.02515134824

P YeB MarinielloF ManteroG-protein-coupled receptors in aldosterone-producing adenomas: a potential cause of hyperaldosteronismJ Endocrinol1953948200710.1677/JOE-07-003717911395

L LenziniTM SecciaE AldighieriHeterogeneity of aldosterone-producing adenomas revealed by a whole transcriptome analysisHypertension5011061113200710.1161/HYPERTENSIONAHA.107.10043817938379

K Saner-AmighBA MayhewF ManteroElevated expression of luteinizing hormone receptor in aldosterone-producing adenomasJ Clin Endocrinol Metabol9111361142200610.1210/jc.2005-129816332935

T WangF SatohR MorimotoGene expression profiles in aldosterone-producing adenomas and adjacent adrenal glandsEur J Endocrinol164613619201110.1530/EJE-10-108521248073

O ZwermannDM SchulteM ReinckeF BeuschleinACTH 1–24 inhibits proliferation of adrenocortical tumors in vivoEur J Endocrinol1534354442005

S BoulkrounB Samson-CouterieJF Golib-DzibAldosterone-producing adenoma formation in the adrenal cortex involves expression of stem/progenitor cell markersEndocrinology15247534763201110.1210/en.2011-120521971159

H ShibataY IkedaT MukaiExpression profiles of COUP-TF, DAX-1, and SF-1 in the human adrenal gland and adrenocortical tumors: possible implications in steroidogenesisMol Genet Metab74206216200110.1006/mgme.2001.323111592817

P ValAM Lefrançois-MartinezG VeyssièreA MartinezSF-1 a key player in the development and differentiation of steroidogenic tissuesNucl Recept18200310.1186/1478-1336-1-814594453

M ReinckeF BeuschleinAC LatronicoExpression of adrenocorticotrophic hormone receptor mRNA in human adrenocortical neoplasms: correlation with P450scc expressionClin Endocrinol (Oxf)46619626199710.1046/j.1365-2265.1997.1991009.x9231058

A LacroixI BourdeauA LampronAberrant G-protein coupled receptor expression in relation to adrenocortical over-functionClin Endocrinol (Oxf)73115201019719763

O ZwermannF BeuschleinE LalliClinical and molecular evidence for DAX-1 inhibition of steroidogenic factor-1-dependent ACTH receptor gene expressionEur J Endocrinol152769776200510.1530/eje.1.0190815879363

KL ParkerBP SchimmerSteroidogenic factor 1: a key determinant of endocrine development and functionEndocrine Rev18361377199710.1210/edrv.18.3.03019183568

H SasanoS ShizawaT SuzukiTranscription factor adrenal 4 binding protein as a marker of adrenocortical malignancyHum Pathol2611541156199510.1016/0046-8177(95)90280-57557951

S SbieraS SchmullG AssieHigh diagnostic and prognostic value of steroidogenic factor-1 expression in adrenal tumorsJ Clin Endocrinol Metab95E161E171201010.1210/jc.2010-065320660055

J OuyangD HuB WangDifferential effects of down-regulated steroidogenic factor-1 on basal and angiotensin II-induced aldosterone secretionJ Endocrinol Invest34671675201121169726

D HuJ OuyangZ WuElementary studies on elevated steroidogenic factor-1 expression in aldosterone-producing adenomaUrol Oncol30457462201210.1016/j.urolonc.2010.03.00120875752

E ZazopoulosE LalliDM StoccoDNA binding and transcriptional repression by DAX-1 blocks steroidogenesisNature390311315199710.1038/368999384387

E LalliMH MelnerDM StoccoP Sassone-CorsiDAX-1 blocks steroid production at multiple levelsEndocrinology1394237424319989751505

M ReinckeF BeuschleinE LalliDAX-1 expression in human adrenocortical neoplasms: implications for steroidogenesisJ Clin Endocrinol Metab8325972600199810.1210/jcem.83.7.50959661652

M ReinckeF BeuschleinM SlawikK BormMolecular adrenocortical tumourigenesisEur J Clin Invest30Suppl 3S63S68200010.1046/j.1365-2362.2000.0300s3063.x

T KonoF IkedaF OsekoNormotensive primary aldosteronism: report of a caseJ Clin Endocrinol Metab5210091013198110.1210/jcem-52-5-10096262353